Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA)

NCT07530263 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Chronic Pulmonary Aspergillosis

Interventions

DRUG: 12 mg of nebulised 99mTc-liposomal amphotericin B
DRUG: 24 mg of nebulised 99mTc-liposomal amphotericin B
RADIATION: SPECT/CT scan

Sponsor

Radboud University Medical Center

Collaborators

[object Object]